Ajanta Pharma Limited Discontinued
FDA Approved Drugs

Ajanta Pharma Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 42
  • Latest Approval Date Mar 26, 2025
  • Data Source FDA
  • First Approval Date Jul 31, 2015
All
191
View
Unclassified
12
View
Discontinued
42
View
RX
137
View
Company Overview

Company

Ajanta Pharma Limited Discontinued

Country

India

Website

Visit Website

Email

info@ajantapharma.com

Social Profiles

Company Snapshot

Ajanta Pharma Limited Discontinued

98, Ajanta House, Charkop, Kandivili (West) Mumbai, 400 067, India

India

www.ajantapharma.com/ info@ajantapharma.com View on Map
FDA Approved Drug Records ( 42 records )
2023
11 Sep
Discontinued Application: 211151

Drug Name

ACETAZOLAMIDE

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2023-09-11

211151 / 1

Active Ingredient

ACETAZOLAMIDE

Application Number

211151

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2023-09-11

Regulatory Status

Discontinued

2023
11 Sep
Discontinued Application: 211151

Drug Name

ACETAZOLAMIDE

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2023-09-11

211151 / 2

Active Ingredient

ACETAZOLAMIDE

Application Number

211151

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2023-09-11

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-02-03

213718 / 1

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-02-03

213718 / 2

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-02-03

213718 / 3

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-02-03

213718 / 4

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-02-03

213718 / 5

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
03 Feb
Discontinued Application: 213718

Drug Name

BREXPIPRAZOLE

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-02-03

213718 / 6

Active Ingredient

BREXPIPRAZOLE

Application Number

213718

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-02-03

Regulatory Status

Discontinued

2023
24 Mar
Discontinued Application: 216193

Drug Name

CARBAMAZEPINE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-03-24

216193 / 1

Active Ingredient

CARBAMAZEPINE

Application Number

216193

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-03-24

Regulatory Status

Discontinued

2023
24 Mar
Discontinued Application: 216193

Drug Name

CARBAMAZEPINE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2023-03-24

216193 / 2

Active Ingredient

CARBAMAZEPINE

Application Number

216193

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2023-03-24

Regulatory Status

Discontinued

2023
24 Mar
Discontinued Application: 216193

Drug Name

CARBAMAZEPINE

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2023-03-24

216193 / 3

Active Ingredient

CARBAMAZEPINE

Application Number

216193

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2023-03-24

Regulatory Status

Discontinued

2020
02 Oct
Discontinued Application: 213897

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-10-02

213897 / 1

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213897

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-10-02

Regulatory Status

Discontinued

2020
02 Oct
Discontinued Application: 213897

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-10-02

213897 / 2

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213897

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-10-02

Regulatory Status

Discontinued

2020
02 Oct
Discontinued Application: 213897

Drug Name

CLOMIPRAMINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-10-02

213897 / 3

Active Ingredient

CLOMIPRAMINE HYDROCHLORIDE

Application Number

213897

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-10-02

Regulatory Status

Discontinued

2018
24 Sep
Discontinued Application: 211012

Drug Name

DOXYCYCLINE HYCLATE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2018-09-24

211012 / 1

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

211012

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2018-09-24

Regulatory Status

Discontinued

2018
24 Sep
Discontinued Application: 211012

Drug Name

DOXYCYCLINE HYCLATE

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-09-24

211012 / 2

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

211012

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2018-09-24

Regulatory Status

Discontinued

2015
10 Dec
Discontinued Application: 203685

Drug Name

IRBESARTAN

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2015-12-10

203685 / 1

Active Ingredient

IRBESARTAN

Application Number

203685

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2015-12-10

Regulatory Status

Discontinued

2015
10 Dec
Discontinued Application: 203685

Drug Name

IRBESARTAN

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2015-12-10

203685 / 2

Active Ingredient

IRBESARTAN

Application Number

203685

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2015-12-10

Regulatory Status

Discontinued

2015
10 Dec
Discontinued Application: 203685

Drug Name

IRBESARTAN

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2015-12-10

203685 / 3

Active Ingredient

IRBESARTAN

Application Number

203685

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2015-12-10

Regulatory Status

Discontinued

2016
14 Oct
Discontinued Application: 203957

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2016-10-14

203957 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

203957

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2016-10-14

Regulatory Status

Discontinued

2016
14 Oct
Discontinued Application: 203957

Drug Name

LANSOPRAZOLE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2016-10-14

203957 / 2

Active Ingredient

LANSOPRAZOLE

Application Number

203957

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2016-10-14

Regulatory Status

Discontinued

2015
31 Jul
Discontinued Application: 203328

Drug Name

MONTELUKAST SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2015-07-31

203328 / 1

Active Ingredient

MONTELUKAST SODIUM

Application Number

203328

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2015-07-31

Regulatory Status

Discontinued

2015
31 Jul
Discontinued Application: 203328

Drug Name

MONTELUKAST SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-07-31

203328 / 2

Active Ingredient

MONTELUKAST SODIUM

Application Number

203328

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-07-31

Regulatory Status

Discontinued

2015
31 Jul
Discontinued Application: 203432

Drug Name

MONTELUKAST SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-07-31

203432 / 1

Active Ingredient

MONTELUKAST SODIUM

Application Number

203432

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-07-31

Regulatory Status

Discontinued

2017
30 May
Discontinued Application: 204320

Drug Name

OLANZAPINE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-05-30

204320 / 1

Active Ingredient

OLANZAPINE

Application Number

204320

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-05-30

Regulatory Status

Discontinued

2017
30 May
Discontinued Application: 204320

Drug Name

OLANZAPINE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2017-05-30

204320 / 2

Active Ingredient

OLANZAPINE

Application Number

204320

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2017-05-30

Regulatory Status

Discontinued

2017
30 May
Discontinued Application: 204320

Drug Name

OLANZAPINE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2017-05-30

204320 / 3

Active Ingredient

OLANZAPINE

Application Number

204320

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2017-05-30

Regulatory Status

Discontinued

2017
30 May
Discontinued Application: 204320

Drug Name

OLANZAPINE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2017-05-30

204320 / 4

Active Ingredient

OLANZAPINE

Application Number

204320

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2017-05-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-08-30

206711 / 1

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-08-30

206711 / 2

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2016-08-30

206711 / 3

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2016-08-30

206711 / 4

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

5

Dosage Form

-

Strength

15MG

Approval Date

2016-08-30

206711 / 5

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

5

Dosage Form

-

Strength

15MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2016
30 Aug
Discontinued Application: 206711

Drug Name

OLANZAPINE

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2016-08-30

206711 / 6

Active Ingredient

OLANZAPINE

Application Number

206711

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2016-08-30

Regulatory Status

Discontinued

2018
27 Sep
Discontinued Application: 209859

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-09-27

209859 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

209859

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-09-27

Regulatory Status

Discontinued

2018
27 Sep
Discontinued Application: 209859

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-09-27

209859 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

209859

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-09-27

Regulatory Status

Discontinued

2019
20 May
Discontinued Application: 205483

Drug Name

SOLIFENACIN SUCCINATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

205483 / 1

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

205483

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

Regulatory Status

Discontinued

2019
20 May
Discontinued Application: 205483

Drug Name

SOLIFENACIN SUCCINATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

205483 / 2

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

205483

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

Regulatory Status

Discontinued

2020
04 Dec
Discontinued Application: 213621

Drug Name

TETRABENAZINE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2020-12-04

213621 / 1

Active Ingredient

TETRABENAZINE

Application Number

213621

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2020-12-04

Regulatory Status

Discontinued

2020
04 Dec
Discontinued Application: 213621

Drug Name

TETRABENAZINE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2020-12-04

213621 / 2

Active Ingredient

TETRABENAZINE

Application Number

213621

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2020-12-04

Regulatory Status

Discontinued

2025
13 Jan
Discontinued Application: 218401

Drug Name

THEOPHYLLINE

Product Number

1

Dosage Form

-

Strength

450MG

Approval Date

2025-01-13

218401 / 1

Active Ingredient

THEOPHYLLINE

Application Number

218401

Product Number

1

Dosage Form

-

Strength

450MG

Approval Date

2025-01-13

Regulatory Status

Discontinued

2025
26 Mar
Discontinued Application: 218401

Drug Name

THEOPHYLLINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-03-26

218401 / 2

Active Ingredient

THEOPHYLLINE

Application Number

218401

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-03-26

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    3 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    191 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
42 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAZOLAMIDE

Application Number

211151

Product Number

1

Active Ingredient

ACETAZOLAMIDE

Dosage Form

-

Strength

125MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit